Lemonaid Health News and Activities

Lemonaid Health is owned by 23andMe.

23andMe is a company listed under the stock ticker ME (US).

They are in:

• Biotechnology50%
• Healthcare50%

Acquisition, funding and merger involving 23andMe.

• Regeneron Pharmaceuticals has announced the acquisition of 23andMe  (posted on May 20 2025).
• 23andMe has filed for bankruptcy protection  (posted on March 25 2025).

View the org chart displaying its 5 main executives

Most searched biographies at Lemonaid Health

• Campbell Murray, Director
• Lana Ghanem, Director
• Eland Siddle, Head of Pharmacy

Popular executive movements at 23andMe

• Kael Reicin has joined the company as Chief Financial Officer  (posted on November 14 2025).
• Stephen Quake has joined the company as Director  (posted on November 14 2025).
• Brad Margus has joined the company as Director  (posted on November 14 2025).

Create your alert
to follow the executive moves at Lemonaid Health.

23andMe has 3,511 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Adaptive Innovations has just announced a $50 Million fundraising (posted on June 4 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by Lemonaid Health

Social media about Lemonaid Health

• Lemonaid Health on Wikipedia, Google News & Yahoo Finance
• Lemonaid Health on LinkedIn, X (Twitter) & YouTube